Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study for High Dose Therapy and Autologous Stem Cell Transplantation in Early Stages of CLL

NCT00275015 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00275015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00275015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study for High Dose Therapy and Autologous Stem Cell Transplantation in Early Stages of CLL
Lead sponsor
German CLL Study Group
Phase
Phase 2
Overall status
Completed
Start date
January 31, 1998
Completion date
April 30, 2012
Enrollment
169 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia